Taken together, our data clearly indicated that celastrol treatment downregulated Claspin and Bcl-2, at least in part, in an m6A-YTHDF3-mediated manner in pancreatic cancer cells. The gene discussed is YTHDF3; the disease is familial pancreatic carcinoma.